Prostate cancer incidence across stage,NCCN risk groups,and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Prostate cancer incidence across stage,NCCN risk groups,and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012

Authors:	Santino S. Butler Vinayak Muralidhar MD MSc Shuang G. Zhao MD Nina N. Sanford MD Idalid Franco MD MPH Zoe H. Fullerton Janice Chavez MSW Anthony V. D’Amico MD Felix Y. Feng MD Timothy R. Rebbeck PhD Paul L. Nguyen MD Brandon A. Mahal MD

Affiliation:	1. Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts;2. Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan;3. Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas;4. University of California, San Francisco, California;5. Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts Harvard T.H. Chan School of Public Health, Boston, Massachusetts

Abstract:

Keywords:	prostatic neoplasms PSA screening incidence prostate cancer